Sermorelin 1000 mcg/mL SUB-Q* Injection recalled over sterility concerns
- Recall date
- September 3, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Kalman Health & Wellness, Inc. dba Essential Wellness Pharma recalls Sermorelin 1000 mcg/mL SUB-Q* Injection, packaged in a) 3 mL, b) 6mL, c) 7.5ml, d) 9 mL or e) 10 mL vials, Rx only, Ess…
- Recall number
- D-325-2016
- FDA classification
- Class II
- Brand / firm
- Kalman Health & Wellness, Inc. dba Essential Wellness Pharma
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility: A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sermorelin 1000 mcg/mL SUB-Q* Injection, packaged in a) 3 mL, b) 6mL, c) 7.5ml, d) 9 mL or e) 10 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.
Get recall alerts
Free email alert whenever Kalman Health & Wellness, Inc. dba Essential Wellness Pharma has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Kalman Health & Wellness, Inc. dba Essential Wellness Pharma